Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07185776 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 200 to confirmed 203 · Site details revised at 2 of 2 sitesv4 Show 2 more changesShow less
    • Enrollment target: estimated 200 to confirmed 203
    • Site details revised at 2 of 2 sites
  2. Start date changed from estimate of Oct 2025 to Oct 21, 2025v3
  3. Trial status: Not Yet Recruiting to Recruiting Site details revised at 2 of 2 sitesv2 Show 1 more changeShow less
    • Site details revised at 2 of 2 sites
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main purpose of this study is to evaluate the efficacy and safety of HRS-5632 in adult participants with elevated Lipoprotein(a) (Lp(a)) at high risk for cardiovascular events.
Trial Details
NCT Number NCT07185776
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Lipoprotein Disorder
Enrollment 203 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov